twitter-logo

NEWS


QT Informatics co-authors cardiac modelling review paper

QT Informatics is the lead author of a recently published review article that discusses the state of the [...]

Crediblemeds

The excellent resource Crediblemeds gathers information about prescription drugs that may cause concern with respect to altering cardiac [...]

Example study

Understanding the balance of multiple ion channel block is not a straightforward process, particularly when inter individual effects [...]

Picking apart multichannel inhibition?

A research paper in the journal Nature Scientific Reports highlights the ion channel properties of a novel compound for [...]

services-icon

SERVICES

QT Informatics offers a mix of data consultancy and in-silico cardiac toxicity expertise, primarily to clients in the Biotech and Pharmaceutical industry.

Our services include performing mathematical simulations of a single virtual heart cell in the absence and presence of a virtual drug.

QT Informatics is an advocate of the improved representation of data. We are passionate about presenting information in a visual and intuitive way, which encourages our clients to ask questions of their own data in a way that is more natural, timely and creative!

QT Informatics provides expertise in the use of modelling and simulation techniques to drug discovery questions. We also provide competitively priced bespoke simulation results for novel discovery and development compounds and provide graphical simulated concentration effect curves for a number of key cardiac cell outputs, such as action potential duration (APD) and upstroke velocity (dV/dt).

QT Informatics is a consultancy founded in 2014 to address an increasing interest in the drug development industry for in silico cardiac modelling. For example we use mathematical descriptions of cardiac cell electrophysiology to provide simulation results and offer support to clients within the pharmaceutical industry in the use and utility of these approaches.

Mark Davies PhD is the Founder and Principal Consultant at QT Informatics. He has broad experience of experimental techniques and their application to modelling and simulation techniques gained from over 10 years at AstraZeneca and in the Computational Cardiovascular Science group at the University of Oxford.

About QT Informatics

ABOUT


Mark Davies PhD is the Founder
and Principal Consultant at QT Informatics.

He has broad experience of experimental techniques and their application to modelling and simulation techniques gained from over 10 years at AstraZeneca and in the Computational Cardiovascular Science group at the University of Oxford.

View Credentials

CONTACT

QT Informatics provides its expertise to clients within Europe and the US.

If you feel inspired by our expertise and would like to discuss a project of your own, please contact us.

BioHub at Alderley Park , Alderley Edge, United Kingdom, SK10 4TG

+44 (0)7720 837756
enquiries@qtinformatics.com

Fields marked with an * are required